Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli (2025)
- Authors:
- USP affiliated authors: MONTEIRO, GISELE - FCF ; PESSOA JUNIOR, ADALBERTO - FCF
- Unidade: FCF
- DOI: 10.3390/ijms26146919
- Subjects: LEUCEMIA; PROTEÍNAS RECOMBINANTES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Molecular Sciences
- ISSN: 1661-6596
- Volume/Número/Paginação/Ano: v. 26, n. 14, p. 1-29 art. 6919, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
PEDROSO, Alejandro et al. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli. International Journal of Molecular Sciences, v. 26, n. 14, p. 1-29 art. 6919, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26146919. Acesso em: 13 fev. 2026. -
APA
Pedroso, A., Miranda, J., Lefin, N., Effer, B., Reyanldo, E. P., Calle, Y., et al. (2025). Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli. International Journal of Molecular Sciences, 26( 14), 1-29 art. 6919. doi:10.3390/ijms26146919 -
NLM
Pedroso A, Miranda J, Lefin N, Effer B, Reyanldo EP, Calle Y, Monteiro G, Pessoa Junior A, Farías JG. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli [Internet]. International Journal of Molecular Sciences. 2025 ; 26( 14): 1-29 art. 6919.[citado 2026 fev. 13 ] Available from: https://dx.doi.org/10.3390/ijms26146919 -
Vancouver
Pedroso A, Miranda J, Lefin N, Effer B, Reyanldo EP, Calle Y, Monteiro G, Pessoa Junior A, Farías JG. Toward Safer Biotherapeutics: Expression and Characterization of a Humanized Chimeric L-Asparaginase in E. coli [Internet]. International Journal of Molecular Sciences. 2025 ; 26( 14): 1-29 art. 6919.[citado 2026 fev. 13 ] Available from: https://dx.doi.org/10.3390/ijms26146919 - Producing L-asparaginase of Erwinia chrysanthemi improved by synthetic evolution of proteins
- Engineered erwinase with possible fewer adverse effects for treatment of acute lymphoblastic leukemia
- Enzima da levedura do pão pode ser alternativa para tratar leucemia infantil
- Heterologous expression and purification of active L-Asparaginase I of Saccharomyces cerevisiae in Escherichia coli host
- Influence and effect of osmolytes in biopharmaceutical formulations
- Double mutant l-asparaginase of Erwinia chrysanthem which may have minor adverse effects
- Characterization of a new microbial ASNase with unique structural characteristics and high citotoxicity over acute lymphoblastic leukemia cells
- Fed-Batch Production of Saccharomyces cerevisiae L-Asparaginase II by Recombinant Pichia pastoris MUTs Strain
- Randomized and rational modifications of the Escherichia coli asparaginase aiming to enhance its effectiveness in the treatment of the lymphatic cancers
- Mutant L-asparaginase of Dickeya chrysanthemi (Erwinia chrysanthemi) with better biochemical parameters
Informações sobre o DOI: 10.3390/ijms26146919 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3272409.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
